RetinalGenix Technologies Inc.
RTGN- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001836295
No open-market purchases or sales by RetinalGenix Technologies Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of RTGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of RetinalGenix Technologies Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of RetinalGenix Technologies Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on RetinalGenix Technologies Inc., newest first.
No Schedule 13D or 13G filings on RetinalGenix Technologies Inc. are on file.
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell RetinalGenix Technologies Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 20233:35 PM ET | Bayern Steven10% stockholder | 10.0K | $44.9K | Nov 7, 2023 | Fidelity Brokerage Services LLC | SEC |
| Aug 31, 202311:21 AM ET | Bayern Steven10% stockholder | 10.0K | $94.0K | Aug 31, 2023 | Fidelity Brokerage Services LLC | SEC |